Robert Flowers - ProAssurance Lead Independent Director
| PRA Stock | USD 16.73 0.23 1.39% |
Director
Dr. Robert E. Flowers, M.D., is an Independent Director of ProAssurance Corporationrationration. He has served as a director of ProAssurance since June 2001 and served as our lead director from 2012 to 2018. Prior to June 2001, Dr. Flowers served as a director of our insurance subsidiary, ProAssurance Indemnity Company, Inc. from 1985 to 2001, and as a director of its former holding company, Medical Assurance, Inc. since 2018.
| Age | 70 |
| Tenure | 6 years |
| Address | 100 Brookwood Place, Birmingham, AL, United States, 35209 |
| Phone | 205 877 4400 |
| Web | https://www.proassurance.com |
Robert Flowers Latest Insider Activity
Tracking and analyzing the buying and selling activities of Robert Flowers against ProAssurance stock is an integral part of due diligence when investing in ProAssurance. Robert Flowers insider activity provides valuable insight into whether ProAssurance is net buyers or sellers over its current business cycle. Note, ProAssurance insiders must abide by specific rules, including filing SEC forms every time they buy or sell ProAssurance'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Robert Flowers over three months ago Disposition of 1510 shares by Robert Flowers of Construction Partners at 56.51 subject to Rule 16b-3 |
ProAssurance Management Efficiency
The current year's Return On Tangible Assets is expected to grow to -0.0066. In addition to that, Return On Capital Employed is expected to decline to 0. At present, ProAssurance's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 5.8 B, whereas Total Assets are forecasted to decline to about 3.9 B. ProAssurance's management efficiency ratios could be used to measure how well ProAssurance manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| George Cochran | Kemper | 66 | |
| Joseph Brown | Global Indemnity PLC | 75 | |
| Robert Stricker | Horace Mann Educators | 73 | |
| Jordan Graham | RLI Corp | 60 | |
| Michael Angelina | RLI Corp | 54 | |
| Bruce Lederman | Global Indemnity PLC | 77 | |
| James Wehr | Global Indemnity PLC | 62 | |
| Daniel Domenech | Horace Mann Educators | 74 | |
| Susan Fleming | RLI Corp | 50 | |
| Lacy Johnson | Kemper | 68 | |
| Kaj Ahlmann | RLI Corp | 70 | |
| Debbie Roberts | RLI Corp | 56 | |
| Robert Restrepo | RLI Corp | 70 | |
| Susan Whiting | Kemper | 64 | |
| Stephen Hasenmiller | Horace Mann Educators | 68 | |
| Teresa Canida | Kemper | 67 | |
| Stuart Parker | Kemper | 59 | |
| David Storch | Kemper | 67 | |
| Calvin Butler | RLI Corp | 51 | |
| Jason Hurwitz | Global Indemnity PLC | 47 | |
| Kathleen Cronin | Kemper | 57 | |
Management Performance
| Return On Equity | 0.0383 | ||||
| Return On Asset | 0.0095 |
ProAssurance Leadership Team
Elected by the shareholders, the ProAssurance's board of directors comprises two types of representatives: ProAssurance inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ProAssurance. The board's role is to monitor ProAssurance's management team and ensure that shareholders' interests are well served. ProAssurance's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ProAssurance's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Edward Rand, President, Chief Executive Officer, Director | ||
| Jeffrey Lisenby, Executive Vice President, General Counsel, Corporate Secretary, head of the corporate Legal Department | ||
| Dana CPA, Treasurer VP | ||
| CPA Rand, CEO President | ||
| Scott Syphax, Director | ||
| Samuel Piazza, Independent Director | ||
| Maye Frei, Independent Director | ||
| Jeffrey Esq, General EVP | ||
| Frank Spinosa, Independent Director | ||
| Heather Wietzel, Senior Relations | ||
| Katisha Vance, Independent Director | ||
| Ross DPM, President America | ||
| Fabiola Cobarrubias, Director | ||
| Kathryn Esq, Chief VP | ||
| Magnus Gorrie, Independent Director | ||
| SPHR CCP, Chief VP | ||
| Darryl Thomas, Senior Officer | ||
| Frank ONeil, Senior Vice President Chief Communications Officer and Investor Relations | ||
| Kedrick Adkins, Independent Director | ||
| Kevin Shook, President of Eastern subsidiary | ||
| Noreen Dishart, Chief Human Resources Officer, Executive Vice President | ||
| Michael CPCU, Pres Segment | ||
| Ziad Haydar, Independent Director | ||
| Robert Flowers, Lead Independent Director | ||
| CPA CPA, Treasurer VP | ||
| Michael Stoeckert, CTO VP | ||
| William Starnes, Chairman of the Board and Presidentident, CEO | ||
| Luke DPM, Chief Director | ||
| Michael Boguski, President of ProAssurance’s Specialty P&C Operations | ||
| Dana Hendricks, Chief Financial Officer, Executive Vice President, Corporate Treasurer | ||
| Karen JD, President Sciences | ||
| Bruce Angiolillo, Independent Director | ||
| Frank IRC, Senior Relations | ||
| Robert Francis, President Liability | ||
| Thomas Wilson, Lead Independent Director | ||
| Lawrence Cochran, Head Officer | ||
| Kevin CPA, President Group | ||
| Ross Taubman, President Chief Medical Officer of PICA |
ProAssurance Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ProAssurance a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0383 | ||||
| Return On Asset | 0.0095 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.1 % | ||||
| Current Valuation | 1.25 B | ||||
| Shares Outstanding | 51.16 M | ||||
| Shares Owned By Insiders | 1.45 % | ||||
| Shares Owned By Institutions | 86.47 % | ||||
| Number Of Shares Shorted | 680.58 K | ||||
| Price To Earning | 26.68 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether ProAssurance offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ProAssurance's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Proassurance Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Proassurance Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProAssurance. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade ProAssurance Stock refer to our How to Trade ProAssurance Stock guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Property & Casualty Insurance space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProAssurance. If investors know ProAssurance will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProAssurance listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.519 | Earnings Share 0.84 | Revenue Per Share 22.73 | Quarterly Revenue Growth 0.034 | Return On Assets 0.0095 |
The market value of ProAssurance is measured differently than its book value, which is the value of ProAssurance that is recorded on the company's balance sheet. Investors also form their own opinion of ProAssurance's value that differs from its market value or its book value, called intrinsic value, which is ProAssurance's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProAssurance's market value can be influenced by many factors that don't directly affect ProAssurance's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProAssurance's value and its price as these two are different measures arrived at by different means. Investors typically determine if ProAssurance is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProAssurance's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.